Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma (pages 663–669)Hideaki Shimada, Akihiko Takeda, Yoshihiro Nabeya, Shin-ichi Okazumi, Hisahiro Matsubara, Yutaka Funami, Hideki Hayashi, Yoshio Gunji, Susumu Kobayashi, Takao Suzuki and Takenori Ochiai
Article first published online: 9 AUG 2001 | DOI: 10.1002/1097-0142(20010801)92:3<663::AID-CNCR1368>3.0.CO;2-L
Vascular endothelial growth factor (VEGF) has been reported to be a potent inducer of angiogenesis in malignant tumors. Increased serum VEGF concentration (S-VEGF) has been found in patients with various solid tumors and appears to be correlated with tumor burden. In the current study, high S-VEGF was found to be associated with tumor progression, poor patient response to treatment, and poor survival in patients with esophageal squamous cell carcinoma.